Aspiriant LLC’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02M | Hold |
12,128
| – | – | 0.03% | 146 |
|
|
2025
Q1 | $867K | Hold |
12,128
| – | – | 0.03% | 148 |
|
|
2024
Q4 | $545K | Hold |
12,128
| – | – | 0.02% | 184 |
|
|
2024
Q3 | $612K | Hold |
12,128
| – | – | 0.02% | 177 |
|
|
2024
Q2 | $495K | Hold |
12,128
| – | – | 0.02% | 190 |
|
|
2024
Q1 | $519K | Hold |
12,128
| – | – | 0.02% | 196 |
|
|
2023
Q4 | $488K | Buy |
+12,128
| New | +$488K | 0.02% | 192 |
|
|
2022
Q3 | – | Sell |
-3,820
| Closed | -$11K | – | 278 |
|
|
2022
Q2 | $11K | Buy |
3,820
+2,667
| +231% | +$7.68K | ﹤0.01% | 274 |
|
|
2022
Q1 | $4K | Hold |
1,153
| – | – | ﹤0.01% | 274 |
|
|
2021
Q4 | $7K | Hold |
1,153
| – | – | ﹤0.01% | 281 |
|
|
2021
Q3 | $16K | Buy |
+1,153
| New | +$16K | ﹤0.01% | 232 |
|